Daniel Gruskin serves as Executive at LogicBio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Gruskin has executed 3 insider transactions totaling $6.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 16, 2022 involved selling 3,331 shares valued at $0.
Daniel Gruskin currently holds 3,331 shares of LogicBio Therapeutics, Inc. (LOGC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Gruskin has been a net seller of LOGC stock. They have purchased $0 and sold $6.4K worth of shares.
Daniel Gruskin's most recent insider trade was on Nov 16, 2022, when they sold 3,331 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.35 |
| Discretionary |
| Aug 6, 2021 | LOGC | $0 | Option Exercise | 4,798 | $N/A | Discretionary |